Toggle navigation
Campus Access
About MPG.eBooks
Skip to content
Search Tips
Home
>
Search: (("moderatism" OR "moderating") or "moderation")
Language
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文（繁體）
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
All Fields
Title
Person
Topic
ISBN/ISSN
Year
Collection
Advanced
Retain my current filters
author_facet:"CADTH Canadian Drug Expert Committee"
Showing
1
-
20
of
28
Search:
'(("moderatism" OR "moderating") or "moderation")'
,
query time: 0.03s
Book List
0
Sort:
Relevance
Year Descending
Year Ascending
Author
Title
Read Now
1
CADTH Canadian Drug Expert Committee recommendation: Risankizumab (Skyrizi -- Abbvie) : indication : adult patients with moderate to severe plaque psoriasis
Published 2019
CADTH
“
... for the treatment of
moderate
to severe plaque psoriasis in adults only if the following conditions are met: In a...
”
Read Now
2
CADTH Canadian Drug Expert Committee final recommendation: Ixekizumab (Taltz -- Eli Lilly Canada Inc.) : indication: moderate to severe plaque psoriasis
Published 2016
Canadian Agency for Drugs and Technologies in Health
“
... for patients with
moderate
to severe plaque psoriasis...
”
Read Now
3
CADTH Canadian Drug Expert Committee final recommendation: Ixekizumab (Taltz -- Eli Lilly Canada Inc.) : indication: moderate to severe plaque psoriasis
Published 2016
Canadian Agency for Drugs and Technologies in Health
“
... for patients with
moderate
to severe plaque psoriasis...
”
Read Now
4
CADTH Canadian Drug Expert Committee Recommendation: Halobetasol propionate and tazarotene (Duobrii -- Bausch Health, Canada Inc.) : indication : psoriasis, moderate to severe plaq...
Published 2020
Canadian Agency for Drugs and Technologies in Health
“
... in adult patients with
moderate
-to severe plaque psoriasis. HP/TAZ is a combination product composed of a...
”
Read Now
5
CADTH Canadian Drug Expert Committee recommendation: Vedolizumab (Entyvio -- Takeda Canada Inc.) : indication: for the treatment of adult patients with moderately to severely activ...
Published 2021
Canadian Agency for Drugs and Technologies in Health
“
...) be reimbursed for the treatment of adult patients with
moderately
to severely active Crohn disease, only...
”
Read Now
6
CADTH Canadian drug expert committee recommendation: Ustekinumab (Stelara/Stelara I.V. -- Janssen Inc.) : indication : for the treatment of adult patients with
moderately
to severely active ulcerative...
Published 2020
Canadian Agency for Drugs and Technologies in Health
“
...indication : for the treatment of adult patients with
moderately
to severely active ulcerative...
”
Read Now
7
Clinical review report: Upadacitinib (Rinvoq) (AbbVie) : indication : for the treatment of adults with moderately to severely active rheumatoid arthritis who have had an inadequate...
Published 2020
Canadian Agency for Drugs and Technologies in Health
“
... of upadacitinib 15 mg extended-release tablets for once daily administration for the treatment of
moderate
...
”
Read Now
8
Clinical review report: Upadacitinib (Rinvoq) (AbbVie) : indication : for the treatment of adults with moderately to severely active rheumatoid arthritis who have had an inadequate...
Published 2020
Canadian Agency for Drugs and Technologies in Health
“
... of upadacitinib 15 mg extended-release tablets for once daily administration for the treatment of
moderate
...
”
Read Now
9
CADTH Canadian Drug Expert Committee recommendation: Guselkumab (Tremfya -- Janssen Inc.) : indication : for the treatment of adult patients with moderate-to-severe plaque psoriasi...
Published 2018
CADTH
“
... patients with
moderate
-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy...
”
Read Now
10
CADTH Canadian Drug Expert Committee recommendation: Crisaborole (Eucrisa -- Pfizer Canada Inc.) : indication : for topical treatment of mild-to-moderate atopic dermatitis in patie...
Published 2019
CADTH
Read Now
11
CADTH Canadian Drug Expert Committee recommendation: Crisaborole (Eucrisa -- Pfizer Canada Inc.) : indication : for topical treatment of mild-to-moderate atopic dermatitis in patie...
Published 2019
CADTH
Read Now
12
CADTH Canadian Drug Expert Committee recommendation: Guselkumab (Tremfya -- Janssen Inc.) : indication : for the treatment of adult patients with moderate-to-severe plaque psoriasi...
Published 2018
CADTH
“
... patients with
moderate
-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy...
”
Read Now
13
CADTH Canadian drug expert committee recommendation: Upadacitinib (Rinvoq -- abbVie) : indication : for the treatment of adults with moderately to severely active rheumatoid arthri...
Published 2020
Canadian Agency for Drugs and Technologies in Health
“
... antirheumatic drugs (csDMARDs) for the treatment of adult patients with
moderately
to severely active rheumatoid...
”
14
CADTH Canadian drug expert committee recommendation (final): Certolizumab pegol (Cimzia -- UCB Canada Inc.) : indication : treatment of adult patients with moderate-to severe plaqu...
Published 2019
Canadian Agency for Drugs and Technologies in Health
“
...) be reimbursed for the treatment of adult patients with
moderate
-to-severe plaque psoriasis who are candidates...
”
Read Now
15
CADTH Canadian drug expert committee recommendation: Upadacitinib (Rinvoq -- abbVie) : indication : for the treatment of adults with moderately to severely active rheumatoid arthri...
Published 2020
Canadian Agency for Drugs and Technologies in Health
“
... antirheumatic drugs (csDMARDs) for the treatment of adult patients with
moderately
to severely active rheumatoid...
”
Read Now
16
CADTH Canadian Drug Expert Committee recommendation: Efinaconazole (Jublia -- Bausch Health, Canada Inc.) : indication : for the topical treatment of mild to moderate onychomycosis...
Published 2019
CADTH
“
... for the topical treatment of mild to
moderate
onychomycosis (tinea unguium) of toenails. Reasons...
”
Read Now
17
CADTH Canadian Drug Expert Committee recommendation: Efinaconazole (Jublia -- Bausch Health, Canada Inc.) : indication : for the topical treatment of mild to moderate onychomycosis...
Published 2019
CADTH
“
... for the topical treatment of mild to
moderate
onychomycosis (tinea unguium) of toenails. Reasons...
”
Read Now
18
CADTH Canadian Drug Expert Committee recommendation: Tofacinitib (Xeljanz) : indication: for the treatment of adult patients with moderately to severely active ulcerative colitis (...
Published 2019
Canadian Agency for Drugs and Technologies in Health
“
... for the treatment of adult patients with
moderately
to severely active UC with an inadequate response, loss...
”
Read Now
19
CADTH Canadian Drug Expert Committee recommendation: Baricitinib (Olumiant -- Eli Lilly Canada Inc.) : indication : for use in combination with methotrexate (MTX) for the treatment...
Published 2019
Canadian Agency for Drugs and Technologies in Health
“
... in combination with MTX for the treatment of adult patients with
moderate
to severe RA who have responded...
”
Read Now
20
CADTH Canadian Drug Expert Committee recommendation: Baricitinib (Olumiant -- Eli Lilly Canada Inc.) : indication : for use in combination with methotrexate (MTX) for the treatment...
Published 2019
Canadian Agency for Drugs and Technologies in Health
“
... in combination with MTX for the treatment of adult patients with
moderate
to severe RA who have responded...
”
1
2
Back
Narrow Search
Remove Filters
Clear Filter
Author: CADTH Canadian Drug Expert Committee
Year of Publication
From:
To:
Classification
610 - Medicine & health
25
330 - Economics
15
700 - The arts; fine & decorative arts
6
140 - Specific philosophical schools
3
Language
English
28
Collection
National Center for Biotechnology Information
28
Author
CADTH Canadian Drug Expert Committee
Canadian Agency for Drugs and Technologies in Health
22
Search Tools
Get RSS Feed
Share Search
https://ebooks.mpdl.mpg.de/ebooks/Search/Results?filter%5B%5D=author_facet%3A%22CADTH+Canadian+Drug+Expert+Committee%22&lookfor=%28%28%22moderatism%22+OR+%22moderating%22%29+or+%22moderation%22%29&type=AllFields
Send by Email
×
Loading...